biotech IPO

Flexibility and adaptation concept Arrows on cubes following a flexible path
Biotech

'One of the lucky few': Bicara CEO on last year's $326M IPO

“We continue to operate as if we're in a world where financings are hard to achieve,” CEO Claire Mazumdar said after Bicara's $362 million 2024 IPO.
Gabrielle Masson Apr 14, 2025 3:59pm
Wall Street stock exchange finance shares share price Nasdaq

Market volatility adds to 'already challenging' year for IPOs

Apr 11, 2025 9:25am
IPO initial public offering

BioNTech backing powers DualityBio toward $200M Hong Kong IPO

Apr 7, 2025 8:21am
valentines day fail

Deerfield suit says Alcon committed 'Valentine's Day massacre'

Feb 24, 2025 5:20pm
Photo of Wall Street street sign with american flags in the background

Aardvark secures $94M IPO to fund appetite-suppressant trials

Feb 13, 2025 8:10am
Photo of Wall Street street sign with american flags in the background

Sionna goes public in $135M IPO, Aardvark plots $103M listing

Feb 7, 2025 4:40am